Does CABOZANTINIB S-MALATE Cause Psoriasis? 43 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 43 reports of Psoriasis have been filed in association with CABOZANTINIB S-MALATE (CABOMETYX). This represents 0.1% of all adverse event reports for CABOZANTINIB S-MALATE.
43
Reports of Psoriasis with CABOZANTINIB S-MALATE
0.1%
of all CABOZANTINIB S-MALATE reports
0
Deaths
10
Hospitalizations
How Dangerous Is Psoriasis From CABOZANTINIB S-MALATE?
Of the 43 reports, 10 (23.3%) required hospitalization.
Is Psoriasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CABOZANTINIB S-MALATE. However, 43 reports have been filed with the FAERS database.
What Other Side Effects Does CABOZANTINIB S-MALATE Cause?
Diarrhoea (8,282)
Fatigue (6,819)
Off label use (5,245)
Nausea (4,341)
Decreased appetite (4,076)
Blood pressure increased (2,939)
Malignant neoplasm progression (2,718)
Palmar-plantar erythrodysaesthesia syndrome (2,706)
Weight decreased (2,657)
Stomatitis (2,560)
What Other Drugs Cause Psoriasis?
SECUKINUMAB (21,976)
APREMILAST (19,255)
ADALIMUMAB (16,698)
ETANERCEPT (10,818)
RISANKIZUMAB-RZAA (6,896)
METHOTREXATE (6,283)
USTEKINUMAB (4,955)
INFLIXIMAB (3,524)
CERTOLIZUMAB PEGOL (3,428)
IXEKIZUMAB (2,818)
Which CABOZANTINIB S-MALATE Alternatives Have Lower Psoriasis Risk?
CABOZANTINIB S-MALATE vs CAFFEINE
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL-MKNL
CABOZANTINIB S-MALATE vs CALCIFEDIOL
CABOZANTINIB S-MALATE vs CALCIPOTRIENE